Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
McKinsey
Harvard Business School
Johnson and Johnson
Boehringer Ingelheim
Express Scripts

Last Updated: December 6, 2021

DrugPatentWatch Database Preview

Patent: 10,508,085

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 10,508,085
Title:Compounds and methods for IDO and TDO modulation, and indications therefor
Abstract: Disclosed are compounds of Formula I(a): ##STR00001## or a pharmaceutically acceptable salt, a solvate, a tautomer, an isomer or a deuterated analog thereof, wherein R.sup.4, R.sup.5, R.sup.6, R.sup.7, G.sup.1, G.sup.2 and Ring A are as described in any of the embodiments described in this disclosure; compositions thereof; and uses thereof.
Inventor(s): Zhang; Jiazhong (Foster City, CA), Powers; Hannah (San Francisco, CA), Albers; Aaron (San Francisco, CA), Pham; Phuongly (San Francisco, CA), Wu; Guoxian (Foster City, CA), Buell; John (San Francisco, CA), Spevak; Wayne (Berkeley, CA), Guo; Zuojun (Pasadena, CA), Walleshauser; Jack (San Ramon, CA), Zhang; Ying (Fremont, CA)
Assignee: Plexxikon Inc. (Berkeley, CA)
Application Number:15/713,502
Patent Claims:see list of patent claims

Details for Patent 10,508,085

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Recordati Rare Diseases, Inc. ELSPAR asparaginase For Injection 101063 1978-01-10 ⤷  Free Forever Trial 2036-09-22
Genentech, Inc. RITUXAN rituximab Injection 103705 1997-11-26 ⤷  Free Forever Trial 2036-09-22
Genentech, Inc. HERCEPTIN trastuzumab For Injection 103792 1998-09-25 ⤷  Free Forever Trial 2036-09-22
Genentech, Inc. HERCEPTIN trastuzumab For Injection 103792 2017-02-10 ⤷  Free Forever Trial 2036-09-22
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Baxter
Express Scripts
Colorcon
McKinsey
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.